Evommune, Inc. (EVMN) Free cash flow 2024–2025
Evommune, Inc. (EVMN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$76.7MFY2025 · since FY2024: -$58.3M → -$76.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.7M | -31.6% |
| FY2024 | -$58.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice